Project Grant H8E38623

The Centers for Disease Control and Prevention (CDC) awarded a $1,013,739 Cooperative Agreement under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421) to the Wisconsin Department of Health Services to enhance epidemiological and laboratory capacity for emerging infectious disease response. This five-year award, effective August 1, 2024 through July 31, 2029, supports activities to strengthen public...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $10,947,336 Cooperative Agreement to Health Research, Inc. under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323) with a project period from August 1, 2024 to July 31, 2029. The ELC program aims to enhance public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases. Through this award, Health Research, Inc. will deliver a range of services...

This $251,493 federal Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) supports research by the Rector & Visitors of the University of Virginia to develop optimized pooled testing strategies for efficient COVID-19 prevalence tracking and accurate infection diagnosis. The research aims to overcome limitations of traditional group testing by designing advanced pooled testing approaches with strong theoretical performance guarantees that are also...

Numentus Technologies Inc. received a $303,685 Project Grant award from the National Science Foundation on February 15, 2021 to develop rapid planar PCR technology for COVID-19 testing. The award was made under the NSF's Engineering program (CFDA 47.041) to support innovation and excellence in engineering research. Through this funding, Numentus will work to advance the development of planar PCR, a technology that enables highly sensitive COVID-19 detection on a single integrated testing...

The Florida Department of Health received a $5,030,388 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The award will fund activities to strengthen Florida's capacity to detect, respond, prevent, and control infectious disease outbreaks, given the state's large and globally mobile population. Key activities include enhancing epidemiological surveillance,...

This $960,000 National Science Foundation project grant supports the development of a multiplexed plasmon-enhanced lateral flow assay for point-of-care detection of SARS-CoV-2 RNA and antigens. Funded under the NSF Engineering program (CFDA 47.041), the grantee, Washington University, will design, validate and build a novel diagnostic platform with sensitivity exceeding standard laboratory tests. Key deliverables include an ultrasensitive multiplexed lateral flow assay for simultaneous...

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $40.4 million cooperative agreement to Exela Pharma Sciences, LLC (Exela) to expand industrial base capabilities for COVID-19 response. With a period of performance from May 2022 through May 2034, this cooperative agreement will support Exela under the Research on Chemical and Biological Defense program (CFDA 12.360). Through this cooperative agreement, Exela will further the government's...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323) provides $1,576,163 to the Idaho Department of Health & Welfare Financial Services Division to build, strengthen, integrate, and support capacity for epidemiology, laboratory, and health information systems in Idaho. The key activities funded include: maintaining core surveillance staff, processes, and...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $2,475,519 Cooperative Agreement to The Task Force for Global Health, Inc., a non-profit organization based in Decatur, Georgia. The award is funded through the CDC's Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323), which aims to strengthen public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases. Under this Cooperative Agreement, The Task...

This Cooperative Agreement award, issued by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323), provides $1,499,856.00 to the University of Rochester to support the "TRUSTED SCHOOL MESSENGERS PROMOTING NON-MANDATED VACCINATION" project. The objective of this multi-year (Sep 2024 - Sep 2027) effort is to enhance public health infrastructure for detecting, responding to, preventing, and...